Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach.

MLA

Hu, Xinpeng, et al. “Monitoring Imatinib Decreasing Pericyte Coverage and HIF-1α Level in a Colorectal Cancer Model by an Ultrahigh-Field Multiparametric MRI Approach.” Journal of Translational Medicine, vol. 22, no. 1, July 2024, pp. 1–21. EBSCOhost, https://doi.org/10.1186/s12967-024-05497-w.

APA

Hu, X., Ye, K., Bo, S., Xiao, Z., Ma, M., Pan, J., Zhong, X., Zhang, D., Mo, X., Yu, X., Chen, M., Luo, L., & Shi, C. (2024). Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach. Journal of Translational Medicine, 22(1), 1–21. https://doi.org/10.1186/s12967-024-05497-w

Chicago

Hu, Xinpeng, Kunlin Ye, Shaowei Bo, Zeyu Xiao, Mengjie Ma, Jinghua Pan, Xing Zhong, et al. 2024. “Monitoring Imatinib Decreasing Pericyte Coverage and HIF-1α Level in a Colorectal Cancer Model by an Ultrahigh-Field Multiparametric MRI Approach.” Journal of Translational Medicine 22 (1): 1–21. doi:10.1186/s12967-024-05497-w.